• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“安全驾驶,提高警觉”:一项系统综述。

DriveSafe DriveAware: A systematic review.

作者信息

Vito Erin, Barkla Anna, Coventry Linda

机构信息

Sir Charles Gairdner Osborne Park Health Care Group, Osborne Park Hospital, Stirling, Western Australia, Australia.

Centre for Nursing Research, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

出版信息

Australas J Ageing. 2023 Mar;42(1):53-63. doi: 10.1111/ajag.13166. Epub 2023 Jan 5.

DOI:10.1111/ajag.13166
PMID:36602154
Abstract

OBJECTIVES

Driving is an activity of daily living that significantly affects independence, and driving cessation is associated with poor health, lower quality of life, cognitive decline and early entry into care facilities. There is no consensus regarding the best off-road tool to assess driving safety. Therefore, this review explored the diagnostic accuracy, reliability and clinical utility of DriveSafe DriveAware (DSDA) compared with an on-road driving assessment.

METHODS

This review adhered to the PRISMA guidelines. Electronic databases for all English language articles published prior to December 2021 were searched. Studies were assessed for methodological quality and results were synthesised using a narrative descriptive approach.

RESULTS

Six studies were reviewed, consisting of 1332 participants. Four studies assessed diagnostic accuracy, two studies assessed reliability and three were relevant to clinical utility since they used DSDA as a standalone tool. Some studies demonstrated high levels of diagnostic accuracy, with specificity and sensitivity above 90% for those who fall into the safe and unsafe categories (50% of those assessed). Inter-rater reliability showed substantial agreement, and test-retest reliability was demonstrated for all age groups. DSDA was assessed as having high clinical utility (as a standalone tool) based on time taken to conduct, cost effectiveness and equipment required to complete the assessment.

CONCLUSIONS

DriveSafe DriveAware appears to be an ideal tool for the subacute setting; however, at present, inadequate evidence exists to support its use as a standalone tool for directing driving decisions. Further research is required.

摘要

目的

驾驶是一项显著影响独立性的日常生活活动,停止驾驶与健康状况不佳、生活质量降低、认知能力下降以及过早进入护理机构相关。关于评估驾驶安全性的最佳非道路工具尚无共识。因此,本综述探讨了与道路驾驶评估相比,DriveSafe DriveAware(DSDA)的诊断准确性、可靠性和临床实用性。

方法

本综述遵循PRISMA指南。检索了2021年12月之前发表的所有英文文章的电子数据库。评估研究的方法学质量,并采用叙述性描述方法综合结果。

结果

共审查了六项研究,包括1332名参与者。四项研究评估了诊断准确性,两项研究评估了可靠性,三项研究与临床实用性相关,因为它们将DSDA用作独立工具。一些研究显示出较高的诊断准确性,对于属于安全和不安全类别的人(占评估者的50%),特异性和敏感性高于90%。评分者间信度显示出高度一致性,所有年龄组均显示出重测信度。基于进行评估所需的时间、成本效益和设备,DSDA被评估为具有较高的临床实用性(作为独立工具)。

结论

DriveSafe DriveAware似乎是亚急性环境中的理想工具;然而,目前尚无足够证据支持将其用作指导驾驶决策的独立工具。需要进一步研究。

相似文献

1
DriveSafe DriveAware: A systematic review.“安全驾驶,提高警觉”:一项系统综述。
Australas J Ageing. 2023 Mar;42(1):53-63. doi: 10.1111/ajag.13166. Epub 2023 Jan 5.
2
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.

引用本文的文献

1
A systematic review of performance-based functional capacity measures for use in Huntington's disease and evaluation of their suitability for clinical trials.一项关于用于亨廷顿舞蹈症的基于表现的功能能力测量方法的系统综述及其对临床试验适用性的评估。
J Huntingtons Dis. 2025 May;14(2):113-131. doi: 10.1177/18796397251330846. Epub 2025 Apr 3.